Tech Company Financing Transactions

Enveda Biosciences Funding Round

On 6/23/2021, Enveda Biosciences announced $51 million in Series A funding from Lux Capital, Catalio Capital Management and Hummingbird Ventures.

Transaction Overview

Company Name
Announced On
6/23/2021
Transaction Type
Venture Equity
Amount
$51,000,000
Round
Series A
Investors

Lux Capital (Lead Investor) (Zavain Dar)

Catalio Capital Management

Hummingbird Ventures

Private Investors (Chris Gibson)

Private Investors (Matthew De Silva)

Lifeforce Ventures

True Ventures (Rohit Sharma)

Two Sigma Ventures

Village Global

Wireframe Ventures

Proceeds Purpose
This new investment will further power Enveda's data-driven approach to screening, validating, and developing high-potential natural compounds into first-in-class clinical candidates.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1880 S Flatiron Ct. K
Boulder, CO 80301
USA
Email Address
Overview
At Enveda, we're harnessing the complexity of the natural world to tackle today's biggest healthcare challenges. With the help of breakthrough advancements in knowledge graphs, machine learning, and metabolomics, we're discovering the next generation of small molecules.
Profile
Enveda Biosciences LinkedIn Company Profile
Social Media
Enveda Biosciences Company Twitter Account
Company News
Enveda Biosciences News
Facebook
Enveda Biosciences on Facebook
YouTube
Enveda Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Viswa Colluru
  Viswa Colluru LinkedIn Profile  Viswa Colluru Twitter Account  Viswa Colluru News  Viswa Colluru on Facebook
Chief Scientific Officer
Sotirios Karathanasis
  Sotirios Karathanasis LinkedIn Profile  Sotirios Karathanasis Twitter Account  Sotirios Karathanasis News  Sotirios Karathanasis on Facebook
Chief Technical Officer
Joseph Rokicki
  Joseph Rokicki LinkedIn Profile  Joseph Rokicki Twitter Account  Joseph Rokicki News  Joseph Rokicki on Facebook
Vice President
David Healey
  David Healey LinkedIn Profile  David Healey Twitter Account  David Healey News  David Healey on Facebook
Vice President
Bryan Norman
  Bryan Norman LinkedIn Profile  Bryan Norman Twitter Account  Bryan Norman News  Bryan Norman on Facebook
VP - Administration
Daniel Wee
  Daniel Wee LinkedIn Profile  Daniel Wee Twitter Account  Daniel Wee News  Daniel Wee on Facebook
VP - Engineering
Chris Diana
  Chris Diana LinkedIn Profile  Chris Diana Twitter Account  Chris Diana News  Chris Diana on Facebook
VP - Product Management
Hannah Gordon
  Hannah Gordon LinkedIn Profile  Hannah Gordon Twitter Account  Hannah Gordon News  Hannah Gordon on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/23/2021: G2 Crowd venture capital transaction
Next: 6/23/2021: Oyster venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary